Genetic susceptibility to aspergillosis in allogeneic stem-cell transplantation

被引:10
|
作者
Cunha, Cristina [1 ]
Rodrigues, Fernando [2 ]
Zelante, Teresa [1 ]
Aversa, Franco [3 ]
Romani, Luigina [1 ]
Carvalho, Agostinho [1 ,2 ]
机构
[1] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06126 Perugia, Italy
[2] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal
[3] Univ Perugia, Div Hematol & Clin Immunol, Dept Clin & Expt Med, I-06126 Perugia, Italy
关键词
Aspergillosis; stem-cell transplantation; polymorphism; susceptibility; toll-like receptor; Th17; TOLL-LIKE RECEPTORS; HOST-DEFENSE; INVASIVE ASPERGILLOSIS; PULMONARY ASPERGILLOSIS; POLYMORPHISMS; IL-23; TLR4; FUMIGATUS; RESPONSES; INFLAMMATION;
D O I
10.3109/13693786.2010.508797
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Invasive aspergillosis (IA) is a major threat to positive outcomes for allogeneic stem-cell transplantation (allo-SCT) patients. Despite presenting similar degrees of immunosuppression, not all individuals at-risk ultimately develop infection. Therefore, the traditional view of neutropenia as a key risk factor for aspergillosis needs to be accommodated within new conceptual advances on host immunity and its relationship to infection. Polymorphisms in innate immune genes, such as those encoding TLRs, cytokines and cytokine receptors, have recently been associated with susceptibility to IA in allo-SCT recipients. This suggests that understanding host-pathogen interactions at the level of host genetic susceptibility will allow the formulation of new targeted and patient-tailored antifungal therapeutics, including improved donor screening.
引用
收藏
页码:S137 / S143
页数:7
相关论文
共 50 条
  • [1] Allogeneic stem-cell transplantation
    Einsele, H
    Kanz, L
    INTERNIST, 1999, 40 (12): : 1249 - 1256
  • [2] Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation
    Cunha, Cristina
    Aversa, Franco
    Lacerda, Joao F.
    Busca, Alessandro
    Kurzai, Oliver
    Grube, Matthias
    Loeffler, Juergen
    Maertens, Johan A.
    Bell, Alain S.
    Inforzato, Antonio
    Barbati, Elisa
    Almeida, Bruno
    Santos e Sousa, Pedro
    Barbui, Anna
    Potenza, Leonardo
    Caira, Morena
    Rodrigues, Fernando
    Salvatori, Giovanni
    Pagano, Livio
    Luppi, Mario
    Mantovani, Alberto
    Velardi, Andrea
    Romani, Luigina
    Carvalho, Agostinho
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (05): : 421 - 432
  • [3] Innovations in allogeneic stem-cell transplantation
    DiPersio, JF
    Khoury, H
    Haug, J
    Vij, R
    Adkins, DR
    Goodnough, LT
    Brown, RA
    SEMINARS IN HEMATOLOGY, 2000, 37 (01) : 33 - 41
  • [4] ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION
    KESSINGER, A
    SMITH, DM
    STRANDJORD, SE
    LANDMARK, JD
    DOOLEY, DC
    COCCIA, PF
    WARKENTIN, PI
    WEISENBURGER, DD
    ARMITAGE, JO
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 493 - 493
  • [5] Allogeneic stem-cell transplantation for myelofibrosis
    Lavi, Noa
    Rowe, Jacob M.
    Zuckerman, Tsila
    CURRENT OPINION IN HEMATOLOGY, 2017, 24 (06) : 475 - 480
  • [6] ALLOGENEIC PERIPHERAL STEM-CELL TRANSPLANTATION
    SCHMITZ, N
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 742 - 742
  • [7] Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
    Zhang, Lining
    Yang, Fan
    Feng, Sizhou
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [8] Extending the role of allogeneic stem-cell transplantation
    Milojkovic, D
    Mufti, GJ
    LANCET, 2001, 357 (9257): : 652 - 654
  • [9] Allogeneic stem-cell transplantation for early relapse of multiple myeloma after autologous stem-cell transplantation
    Schmidt, V
    Mugge, L-O
    Klink, A.
    Hilgendorf, I
    Hochhaus, A.
    Sayer, H. G.
    Oncology Research and Treatment, 2015, 38 : 128 - 129
  • [10] Allogeneic stem-cell transplantation for renal-cell cancer
    Gommersall, L
    Hayne, D
    Lynch, C
    Joseph, JV
    Arya, M
    Patel, HRH
    LANCET ONCOLOGY, 2004, 5 (09): : 561 - 567